Literature DB >> 2351933

Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis.

W J Zhang1, M A Degli-Esposti, T J Cobain, P U Cameron, F T Christiansen, R L Dawkins.   

Abstract

We have examined the hypothesis that MHC ancestral haplotypes have a specific content of genes regulating the extent of autoimmune reactions. Gene copy number was quantitated by objective densitometry after PFGE was used to separate heterozygous AHs of different lengths. Initially we analyzed examples of known gene copy number at the C4 and 21 hydroxylase loci and showed that the approach provides predictable results. We then studied heterozygotes containing one characterized and one uncharacterized AH with particular attention to the gene copy number at the C4, Cyp21, and DRB loci. Each AH studied has a characteristic gene copy number at each locus studied. The same may be true of TNF, but other possibilities must be considered. AHs are markers for extensive chromosomal segments including particular numbers of several functional genes. Since AHs mark susceptibility to autoimmune disease, differences in gene copy number may be implicated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351933      PMCID: PMC2187943          DOI: 10.1084/jem.171.6.2101

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Phenotyping of human complement component C4, a class-III HLA antigen.

Authors:  E Sim; S J Cross
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

2.  Molecular genetics of the fourth component of human complement.

Authors:  M C Carroll; A Palsdottir; K T Belt; C Y Yu
Journal:  Biochem Soc Symp       Date:  1986

3.  A model for the separation of large DNA molecules by crossed field gel electrophoresis.

Authors:  E M Southern; R Anand; W R Brown; D S Fletcher
Journal:  Nucleic Acids Res       Date:  1987-08-11       Impact factor: 16.971

Review 4.  Major histocompatibility complex polymorphism: a nonimmune theory for selection.

Authors:  L Flaherty
Journal:  Hum Immunol       Date:  1988-01       Impact factor: 2.850

5.  Heterogeneity of steroid 21-hydroxylase genes in classical congenital adrenal hyperplasia.

Authors:  R L Dawkins; E Martin; P H Kay; M J Garlepp; A N Wilton; M S Stuckey
Journal:  J Immunogenet       Date:  1987 Apr-Jun

6.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants.

Authors:  P M Schneider; M C Carroll; C A Alper; C Rittner; A S Whitehead; E J Yunis; H R Colten
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  C4 allotyping on plasma or serum: application to routine laboratories.

Authors:  W J Zhang; P H Kay; T J Cobain; R L Dawkins
Journal:  Hum Immunol       Date:  1988-03       Impact factor: 2.850

8.  Structure of human steroid 21-hydroxylase genes.

Authors:  P C White; M I New; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

9.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.

Authors:  C O Jacob; H O McDevitt
Journal:  Nature       Date:  1988-01-28       Impact factor: 49.962

10.  Effect of tumor necrosis factor alpha on mitogen-activated human B cells.

Authors:  J H Kehrl; A Miller; A S Fauci
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  23 in total

1.  Alloreactivity and association of human natural killer cells with the major histocompatibility complex.

Authors:  E Mavoungou; A Sall; V Poaty-Mavoungou; F S Toure; P Yaba; A Delicat; J Lansoud-Soukate
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Genomic organization of a polymorphic duplicated region centromeric of HLA-B.

Authors:  C Leelayuwat; L J Abraham; H Tabarias; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  The genomic structure of two ancestral haplotypes carrying C4A duplications.

Authors:  K Tokunaga; W J Zhang; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Haplotypic polymorphisms of the TNFB gene.

Authors:  L J Abraham; D C Du; K Zahedi; R L Dawkins; A S Whitehead
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cells.

Authors:  Qin Yuan; Pin Dong Li; Ben Hui Li; Xian Zi Yang; Shuang Bing Xu; Xiao Hong Liu; Fu Xiang Zhou; Wen Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-07       Impact factor: 4.553

6.  The major histocompatability complex (MHC) contains conserved polymorphic genomic sequences that are shuffled by recombination to form ethnic-specific haplotypes.

Authors:  S Gaudieri; C Leelayuwat; G K Tay; D C Townend; R L Dawkins
Journal:  J Mol Evol       Date:  1997-07       Impact factor: 2.395

Review 7.  Inclusion body myositis.

Authors:  M J Garlepp; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

8.  Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins.

Authors:  Erwin K Chung; Yan Yang; Kristi L Rupert; Karla N Jones; Robert M Rennebohm; Carol A Blanchong; C Yung Yu
Journal:  Am J Hum Genet       Date:  2002-09-10       Impact factor: 11.025

9.  Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM.

Authors:  M A Degli-Esposti; L J Abraham; V McCann; T Spies; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  Human copy number polymorphic genes.

Authors:  J A Bailey; J M Kidd; E E Eichler
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.